# Efficacy, Safety and Tolerability of Low Sodium Oxybate for Nocturnal Cluster Headache Attacks

> **NCT06950281** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Leiden University Medical Center** · enrollment: 52 (estimated)

## Conditions studied

- Chronic Cluster Headache

## Interventions

- **DRUG:** Low Sodium Oxybate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06950281
- **Lead sponsor:** Leiden University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01
- **Primary completion:** 2027-12
- **Final completion:** 2028-05
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2025-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06950281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06950281, "Efficacy, Safety and Tolerability of Low Sodium Oxybate for Nocturnal Cluster Headache Attacks". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06950281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*